![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | (2013.01) |
C07K 19/00 | (2006.01) | ||
C07K 7/06 | (2006.01) | ||
C07K 5/06078 | (2013.01) | ||
A61K 38/08 | (2019.01) | ||
A61K 38/29 | (2013.01) | ||
C07K 1/107 | (2006.01) | ||
A61K 38/26 | (2013.01) | ||
A61K 38/00 | (2006.01) | ||
A61K 38/07 | (2013.01) | ||
A61K 38/07 | (2006.01) | ||
A61K 38/095 | (2019.01) | ||
A61K 38/26 | (2006.01) | ||
C07K 7/06 | (2013.01) | ||
A61K 38/29 | (2006.01) | ||
C07K 1/1077 | (2013.01) | ||
A61K 38/08 | (2013.01) | ||
C09D 101/28 | (2006.01) | ||
C07K 5/065 | (2006.01) |
(11) | Number of the document | 3444281 |
(13) | Kind of document | T |
(96) | European patent application number | 18183208.0 |
Date of filing the European patent application | 2013-11-20 | |
(97) | Date of publication of the European application | 2019-02-20 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201261728667 P | 2012-11-20 | US |
(72) |
NESTOR, John, J , US
|
(73) |
Eumederis Pharmaceuticals, Inc. ,
12707 High Bluff Drive, Suite 200, San Diego, CA 92130,
US
|
(54) | IMPROVED PEPTIDE PHARMACEUTICALS |
IMPROVED PEPTIDE PHARMACEUTICALS |